Endocrimeta

What Endocrimeta does

Endocrimeta is a Brazilian clinical analysis laboratory headquartered in Porto Alegre, Rio Grande do Sul, operating more than 80 physical collection points across over 30 municipalities in Rio Grande do Sul and Santa Catarina. Founded in 1970, the company delivers a broad diagnostic testing portfolio spanning basic clinical chemistry (glucose, blood typing), hematology, infectious disease screening (HIV, hepatitis, dengue, COVID-19, STIs via PCR), endocrinology panels (thyroid, vitamins, hormones), genetic testing (fetal sex determination, paternity DNA), and comprehensive check-up combos (women's health with 22 tests, men's health with 19 tests). Underlying technology relies on conventional clinical laboratory methods including PCR and RT-PCR molecular diagnostics, immunoassays, and automated biochemistry analyzers, paired with digital infrastructure for online test purchasing, a results portal, and a mobile at-home collection service.

The business operates a dual-channel model combining direct-to-consumer e-commerce (customers buy tests online for R$9.90 to R$1,100 and visit any collection point for sampling) with direct-billing partnerships through Brazilian health insurers (convênios) including Amil, Bradesco Saúde, Sul América, IPE Saúde, and CASSI. Revenue is generated via one-time per-test purchases (cash or installment up to 4x) and transaction-fee insured billing. Marketing is digital-first, anchored by a health-education blog, organic social, and WhatsApp-based sales and support. The company is part of Grupo WP, among the top 10 independent laboratory groups in Brazil, and holds SENATRAN authorization to perform mandatory toxicology screening for professional driver's license categories C, D, and E, creating a regulated recurring volume stream alongside consumer health testing.

Name

Endocrimeta

Legal name

Endocrimeta

Website

https://endocrimeta.com.br

Company type

Private

Founded year

1970

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Diagnostic Laboratory Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)

akta.pro secondary industry

Allergy & Immunology Diagnostic Testing Centers (Skin/Challenge/PFT) (HLAKAAAL)

Keywords

• Clinical laboratory services
• Diagnostic testing services
• Laboratory collection services
• Health screening panels
• Molecular diagnostic testing

Headquarters

HQ city

Porto Alegre

HQ country

Brazil

HQ region

Latin America

Offices24 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Direct Exam Sales: One-time payment model for individual laboratory tests and combo packages purchased by consumers directly through the website. Prices range from R$9.90 for basic tests like glucose to R$1100 for comprehensive panels like food intolerance testing.
2. Health Insurance Billing: Revenue generated through direct billing with health insurance providers (convênios) for covered laboratory tests performed for insured patients.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels4 records

Core offering

Endocrimeta is a clinical analysis laboratory network operating 80+ collection points across Rio Grande do Sul and Santa Catarina in southern Brazil. The company offers a comprehensive menu of diagnostic tests and health check-up panels (individual exams and combo packages covering biochemistry, hematology, immunology, infectious disease, fertility, genetics, and molecular diagnostics including PCR/RT-PCR respiratory panels), sold directly to consumers through its e-commerce website and serviced at any of its physical collection locations. Additional services include mobile sample collection at the customer's home or workplace, an online results portal, and direct billing with major health insurance providers.

Product overview

Endocrimeta is a clinical laboratory network offering a comprehensive portfolio of diagnostic laboratory tests and health check-up panels. The offering consists of individual tests (such as pregnancy tests, blood typing, glucose tests, vitamin assessments, infectious disease screening, and genetic testing), specialized combo/panel products that bundle multiple related tests at discounted prices (including Combo Saúde da Mulher with 22 tests, Combo Saúde do Homem with 19 tests, thyroid panels, metabolic panels, and STI panels), and molecular diagnostic services (including PCR-based STI detection and RT-PCR respiratory panels). The laboratory also provides mobile collection services for at-home sampling and an online results portal for digital access to test results. Tests can be purchased directly through the website, with results accessible via the online portal. The lab is part of Grupo WP, one of the 10 largest independent laboratories in Brazil.

Differentiator

Problem solved

Functional benefit

Products and services

• Sexagem Fetal (Fetal Sex Determination)

Quantifiable outcome

• Results available same day for rapid testing panels
• +1 more outcomes

Segments4 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Seven partnerships are on record, tiered core.

• AmilcoreChannel Partner/ Reseller/ DistributorMajor health insurance provider partnership. Endocrimeta is an authorized service provider for Amil health plan beneficiaries, allowing direct billing for laboratory services.
• Bradesco SaúdecoreChannel Partner/ Reseller/ DistributorMajor corporate health insurance provider partnership. Endocrimeta accepts Bradesco Saúde for covered laboratory testing services.
• Sul AméricacoreChannel Partner/ Reseller/ DistributorLeading health insurance company partnership. Sul América beneficiaries can access Endocrimeta laboratory services with direct insurance billing.
• IPE SaúdecoreChannel Partner/ Reseller/ DistributorState government employee health plan partnership in Rio Grande do Sul. IPE Saúde beneficiaries have access to Endocrimeta's laboratory network.
• CASSIcoreChannel Partner/ Reseller/ DistributorBanco do Brasil employee health plan partnership. CASSI beneficiaries can use Endocrimeta for laboratory testing services.
• Grupo WPcoreStrategic or Co-development PartnerEndocrimeta is part of Grupo WP, one of the 10 largest independent laboratory groups in Brazil. Grupo WP includes brands Widal Pacheco and Endocrimeta, operating 80+ collection points across 30+ municipalities in Southern Brazil.
• SENATRANcoreOthersGovernment regulatory body for toxicology testing certification. Endocrimeta is authorized by SENATRAN to perform mandatory toxicology tests for CNH categories C, D, and E drivers.

Scale indicators4 records

Recent moves7 records

Broad incumbents

• LabCorp: Major U.S. clinical laboratory network combining routine diagnostics, specialty testing, and consumer-direct purchasing. International benchmark for scaling a hybrid B2C and B2B lab business.
• Quest Diagnostics: Large U.S. clinical laboratory incumbent with deep insurer relationships, broad test menus, and an expanding DTC consumer channel. Useful international reference for the DTC + insurer hybrid model Endocrimeta is building.
• Grupo Fleury: Major Brazilian diagnostics network with premium brand positioning, broad insurer contracts, and expanding into digital health. Represents the upper-bound incumbent in terms of pricing power and breadth of offering.
• Dasa: Largest diagnostics company in Brazil, operating nationally with broad test menus, hospital lab management, and integrated health services. Provides a national-scale benchmark against which Endocrimeta's regional model must compete.

Direct peers

• DB Diagnósticos: Independent Brazilian clinical laboratory network offering similar diagnostic test menus and convênio billing. Comparable in scale, regional footprint, and DTC orientation.
• Grupo Sabin: Brazilian independent diagnostic medicine group with regional density and a comparable mix of clinical analysis, check-up panels, and insurer partnerships. Closest mid-sized independent peer in business model and customer segments.
• Widal Pacheco: Sister brand under Grupo WP alongside Endocrimeta, also operating clinical laboratory services in Southern Brazil. Direct comparison point for shared infrastructure, test menu, and insurer relationships.

Regional players

• Atalaia Saúde: Brazilian regional clinical laboratory with comparable diagnostic testing focus. Relevant as a same-tier independent competitor with overlapping insurer relationships.
• Pasteur Diagnósticos: Independent Brazilian clinical analysis laboratory offering routine and specialized testing with insurer billing. Comparable scale and channel structure.

Emerging players

• Hilab: Brazilian digital diagnostics startup offering remote rapid testing and telemedicine-enabled lab services. Represents an emerging digital-first model that could compete for the same DTC convenience-oriented patient.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xwa.me/5551985171379
• Facebookfacebook.com/endocrimeta
• LinkedInlinkedin.com/company/laboratorio-endocrimeta-de-analises-clinicas

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Endocrimeta